- Home
- MTEK vs LSTA Comparison
MTEK vs LSTA Comparison
Compare MTEK & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- LSTA
- Stock Information
- Founded
- MTEK 2008
- LSTA 1980
- Country
- MTEK Israel
- LSTA United States
- Employees
- MTEK N/A
- LSTA N/A
- Industry
- MTEK
- LSTA Misc Health and Biotechnology Services
- Sector
- MTEK
- LSTA Health Care
- Exchange
- MTEK Nasdaq
- LSTA Nasdaq
- Market Cap
- MTEK 26.9M
- LSTA 23.1M
- IPO Year
- MTEK 2022
- LSTA N/A
- Fundamental
- Price
- MTEK $3.21
- LSTA $2.63
- Analyst Decision
- MTEK
- LSTA Strong Buy
- Analyst Count
- MTEK 0
- LSTA 2
- Target Price
- MTEK N/A
- LSTA $23.50
- AVG Volume (30 Days)
- MTEK 51.2K
- LSTA 55.3K
- Earning Date
- MTEK 08-27-2025
- LSTA 08-11-2025
- Dividend Yield
- MTEK N/A
- LSTA N/A
- EPS Growth
- MTEK N/A
- LSTA N/A
- EPS
- MTEK N/A
- LSTA N/A
- Revenue
- MTEK $6,078,953.00
- LSTA $1,000,000.00
- Revenue This Year
- MTEK N/A
- LSTA N/A
- Revenue Next Year
- MTEK N/A
- LSTA N/A
- P/E Ratio
- MTEK N/A
- LSTA N/A
- Revenue Growth
- MTEK 50.80
- LSTA N/A
- 52 Week Low
- MTEK $1.54
- LSTA $1.87
- 52 Week High
- MTEK $6.47
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- MTEK 51.25
- LSTA 50.08
- Support Level
- MTEK $3.30
- LSTA $2.45
- Resistance Level
- MTEK $3.49
- LSTA $2.80
- Average True Range (ATR)
- MTEK 0.22
- LSTA 0.23
- MACD
- MTEK -0.04
- LSTA -0.00
- Stochastic Oscillator
- MTEK 15.56
- LSTA 44.58
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.